Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPAR-Dependent AMPK Activation

Texto completo
Autor(es):
de Souza, Camila O. ; Teixeira, Alexandre A. S. ; Biondo, Luana A. ; Lima Junior, Edson A. ; Batatinha, Helena A. P. ; Rosa Neto, Jose C.
Número total de Autores: 6
Tipo de documento: Artigo Científico
Fonte: Journal of Cellular Physiology; v. 232, n. 8, p. 2168-2177, AUG 2017.
Citações Web of Science: 16
Resumo

Background: Palmitoleic acid, since described as lipokine, increases glucose uptake by modulation of 5AMP-activated protein kinase (AMPK), as well as increasing lipolysis by activation of peroxisome proliferator-activated receptor- (PPAR), in adipose tissue. However, in liver, the effects of palmitoleic acid on glucose metabolism and the role of PPAR remain unknown. Objective: To investigate whether palmitoleic acid improved the hepatic insulin sensitivity of obese mice. Methods: C57BL6 and PPAR knockout (KO) mice were fed for 12 weeks with a standard diet (SD) or high-fat diet (HF), and in the last 2 weeks were treated with oleic or palmitoleic acid. Results: Palmitoleic acid promoted a faster uptake of glucose in the body, associated with higher insulin concentration; however, even when stimulated with insulin, palmitoleic acid did not modulate the insulin pathway (AKT, IRS). Palmitoleic acid increased the phosphorylation of AMPK, upregulated glucokinase and downregulated SREBP-1. Regarding AMPK downstream, palmitoleic acid increased the production of FGF-21 and stimulated the expression of PPAR. Palmitoleic acid treatment did not increase AMPK phosphorylation, modulate glucokinase or increase FGF-21 in liver of PPAR KO mice. Conclusions: In mice fed with a high-fat diet, palmitoleic acid supplementation stimulated the uptake of glucose in liver through activation of AMPK and FGF-21, dependent on PPAR. J. Cell. Physiol. 232: 2168-2177, 2017. (c) 2016 Wiley Periodicals, Inc. (AU)

Processo FAPESP: 16/01409-8 - Caracterização do efeito antiinflamatório da suplementação com ácido palmitoleico na inflamação hepática; o papel dos ppars.
Beneficiário:José Cesar Rosa Neto
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 13/04765-1 - Efeitos da suplementação com ácido palmitoléico nas alterações imuno-metabólicas hepáticas induzidas por dieta hiperlipídica em camundongos PPAR± -/-
Beneficiário:Camila Oliveira de Souza
Modalidade de apoio: Bolsas no Brasil - Doutorado